[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346522-105":59,"doc-detail-346522-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-relationship-between-genetic-mutations-and-organ-metastasis-in-non-small-cell-lung-cancer","The Relationship Between Genetic Mutations and Organ Metastasis in Non-Small Cell Lung Cancer","","Non-small cell lung cancer is among the most prevalent cancers worldwide, and its high metastatic potential drives poor prognosis and mortality. Molecular testing and high-throughput sequencing have identified driver genes (EGFR, ALK, KRAS) and key non-driver genes (TP53, STK11, KEAP1) that shape NSCLC metastasis. These mutations affect tumor invasiveness, drug resistance, and organ-specific metastatic patterns, supporting mutation-based risk prediction and personalized treatment. Multi-omics integration and expanded clinical research aim to improve metastasis prevention and therapy optimization.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-relationship-between-genetic-mutations-and-organ-metastasis-in-non-small-cell-lung-cancer/346522/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-relationship-between-genetic-mutations-and-organ-metastasis-in-non-small-cell-lung-cancer/346522.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Which genetic mutations are discussed as key drivers of NSCLC metastasis?","Question",{"text":113,"@type":114},"Driver genes include EGFR, ALK, and KRAS, while key non-driver genes highlighted are TP53, STK11, and KEAP1.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do mutations relate to organ-specific metastatic patterns in NSCLC?",{"text":118,"@type":114},"EGFR and ALK mutations are linked to brain metastasis, KRAS mutations are associated with bone, liver, and multiple lung metastases, and TP53/STK11/KEAP1 mutations increase multi-organ metastatic risk.",{"name":120,"@type":111,"acceptedAnswer":121},"What limitations in existing research are mentioned?",{"text":122,"@type":114},"The text notes reliance on retrospective or single-center studies, small sample sizes, and insufficient large-scale prospective data, leaving mechanistic insights fragmented and limiting clinical translation.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},346522,1790182173,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","The relationship between genetic mutations and organ metastasis in non-small cell lung cancer  \nHaiying Xue*, Yuzhu Chen*, Fei Qi*, Kaixuan Chen*, Xiaolin Liu, Muxin Zhang, Ziyuan Gao, Shanshan Cai, Tianbo Gao and Tongmei Zhang  \nAbstract: Non-small cell lung cancer is among the most prevalent cancers worldwide, with its high metastatic potential driving poor prognosis and mortality. Advances in molecular testing and high-throughput sequencing have highlighted the roles of driver genes (EGFR, ALK, KRAS) and key non-driver genes (TP53, STK11, KEAP1) in NSCLC metastasis. These mutations influence tumor invasiveness, drug resistance, and organ-specific metastatic patterns—EGFRand ALK mutations favor brain metastasis, KRAS mutations are linked to bone, liver, and multiple lung metastases, while TP53, STK11, and KEAP1 mutations increase multi-organ metastatic risk. This review summarizes the associations between genetic mutations and metastatic sites, explores underlying molecular mechanisms, and discusses mutation-based risk prediction and personalized therapeutic strategies. With multi-omics integration and further clinical research, genetic profiling may become a key tool for guiding metastasis prevention, early intervention, and treatment optimization in NSCLC.  \nKeywords: circulating tumor cells (CTCs), genetic mutations, non-small cell lung cancer, organ-specific metastasis, pre-metastatic niche (PMN)  \nReceived: 20 August 2025; revised manuscript accepted: 20 January 2026.  \nIntroduction  \nNon-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases, with adenocarcinoma, squamous cell carcinoma, and large cell carcinoma as its main subtypes.1 Despite recent advances in diagnosis and therapy, advanced NSCLC patients still exhibit poor 5-year survival, largely due to metastasis. NSCLC commonly spreads to specific organs, includingthe brain, bones, liver, adrenal glands, and lungs (Figure 1),2 which not only worsen symptoms but also complicate clinical management.  \nHigh-throughput sequencing and molecular testing have revealed the pivotal roles of driver genes (e.g., EGFR, ALK, KRAS) and key non-driver genes (e.g., TP53, STK11, KEAP1) inNSCLC development and progression. These mutations influence tumor proliferation, invasion, and drug resistance, and are closely linked to organ-specific metastasis.3  \nEGFR and ALK mutations are associated with brain metastasis, KRAS with multiple lung, liver, or adrenal metastases, while TP53, STK11, and KEAP1 mutations indicate higher multi-organ metastatic risk and poor prognosis.  \nDespite extensive research on the link between genetic mutations and NSCLC metastasis, gaps remain due to reliance on retrospective or singlecenter studies, small sample sizes, and a lack of large-scale prospective data. Mechanistic insights are still fragmented, and clinical translation is limited, with no established predictive models or standardized treatment protocols based on genetic profiles.4 A systematic summary of gene– metastasis associations in NSCLC can clarify the molecular basis of tumor progression and provide guidance for metastasis risk prediction, personalized therapy, and strategies to overcome drug resistance.  \nTherAdv Med Oncol 2026, Vol. 18: 1–16  \nDOI: 10. 1177/ 17588359261424770 © The Author(s), 2026.  \nArticle reuse guidelines: [sagepub.com/journals](sagepub.com/journals)permissions  \nCorrespondence to:  \nTongmei Zhang  \nDepartment of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, No. 9 Beiguan Street, Tongzhou District, Beijing 101149, China Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China  \n[tongmeibj@163.com](tongmeibj@163.com)[ ](tongmeibj@163.com)Tianbo Gao  \nDepartment of Oncology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China  \n[alice19920612@163.com](alice19920612@163.com)[ ](alice19920612@163.com)Shanshan Cai  \nDi","cbCailpqN5O4qw7k","https://ap.wps.com/l/cbCailpqN5O4qw7k","pdf",849323,16,"English","# Introduction\n## Molecular drivers and non-driver genes in NSCLC\n## Gene–metastasis associations and clinical gaps\n# The process and mechanisms of lung cancer metastasis\n## Multi-step metastasis and tumor microenvironment","[{\"question\":\"Which genetic mutations are discussed as key drivers of NSCLC metastasis?\",\"answer\":\"Driver genes include EGFR, ALK, and KRAS, while key non-driver genes highlighted are TP53, STK11, and KEAP1.\"},{\"question\":\"How do mutations relate to organ-specific metastatic patterns in NSCLC?\",\"answer\":\"EGFR and ALK mutations are linked to brain metastasis, KRAS mutations are associated with bone, liver, and multiple lung metastases, and TP53/STK11/KEAP1 mutations increase multi-organ metastatic risk.\"},{\"question\":\"What limitations in existing research are mentioned?\",\"answer\":\"The text notes reliance on retrospective or single-center studies, small sample sizes, and insufficient large-scale prospective data, leaving mechanistic insights fragmented and limiting clinical translation.\"}]","The Relationship Between Genetic Mutations and Organ Metastasis in Non-Small Cell Lung Cancer | PDF",1790061823,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a8c108363b0d4e1a5687d602d40922c.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0fbd4efe4a48d09280232131a56442b1.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3b96bb65c9aae9f2764b09ab67e03e4.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d35f2c4d9f407766641f1e41114223d4.webp",980,1306]